Skip to main content

Swiss National Bank

Bank

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1582202 ZURICH, V8

Position in RXRX

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$2,692,390
-$253,637 QoQ
Shares Held
877,000
+21.8% QoQ
Ownership
0.166%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RXRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Swiss National Bank holds $1,640,558,253 across 148 Biotechnology names. RXRX ranks #83 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in RXRX

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,692,390 877,000
2025-12-31 $2,946,027 720,300
2025-09-30 $3,028,528 620,600
2025-06-30 $2,864,972 566,200
2025-03-31 $2,556,657 483,300
2024-12-31 $3,290,092 486,700
2024-09-30 $2,353,289 357,100
2024-06-30 $2,664,000 355,200
2024-03-31 $3,075,745 308,500
2023-12-31 $2,774,604 281,400
2023-09-30 $2,173,365 284,100
2023-06-30 $2,087,865 279,500
2023-03-31 $784,392 117,600
2022-12-31 $922,116 119,600
2022-09-30 $1,239,560 116,500
2022-06-30 $918,192 112,800
2022-03-31 $675,188 94,300
2021-12-31 $1,500,588 87,600